SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001607062-16-001092
Filing Date
2016-12-21
Accepted
2016-12-20 18:55:22
Documents
74
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K rgbp093016form10k.htm 10-K 1696155
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 8314
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 8433
4 EXHIBIT 32.1 ex32_1.htm EX-32.1 5071
5 EXHIBIT 32.2 ex32_2.htm EX-32.2 4743
6 EXHIBIT 10.86 ex10_86.htm EX-10.86 28674
7 EXHIBIT 10.85 ex10_85.htm EX-10.85 28925
8 EXHIBIT 10.84 ex10_84.htm EX-10.84 28687
9 EXHIBIT 10.83 ex10_83.htm EX-10.83 28932
16 EXHIBIT 10.82 ex10_82.htm EX-10.82 28696
17 EXHIBIT 10.81 ex10_81.htm EX-10.81 28690
18 EXHIBIT 10.80 ex10_80.htm EX-10.80 28693
19 EXHIBIT 10.79 ex10_79.htm EX-10.79 28692
20 EXHIBIT 10.78 ex10_78.htm EX-10.78 34183
21 EXHIBIT 10.77 ex10_77.htm EX-10.77 34180
22 EXHIBIT 10.76 ex10_76.htm EX-10.76 34177
23 EXHIBIT 10.75 ex10_75.htm EX-10.75 28938
24 EXHIBIT 10.73 ex10_73.htm EX-10.73 29056
25 EXHIBIT 10.72 ex10_72.htm EX-10.72 28842
26 EXHIBIT 10.71 ex10_71.htm EX-10.71 28828
27 EXHIBIT 10.70 ex10_70.htm EX-10.70 8364
  Complete submission text file 0001607062-16-001092.txt   4465014

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE FILE rgbp-20160930.xml EX-101.INS 415645
11 XBRL SCHEMA FILE rgbp-20160930.xsd EX-101.SCH 47983
12 XBRL CALCULATION FILE rgbp-20160930_cal.xml EX-101.CAL 34065
13 XBRL DEFINITION FILE rgbp-20160930_def.xml EX-101.DEF 116533
14 XBRL LABEL FILE rgbp-20160930_lab.xml EX-101.LAB 215865
15 XBRL PRESENTATION FILE rgbp-20160930_pre.xml EX-101.PRE 191680
Mailing Address 4700 SPRING ST #304 LA MESA CA 91942
Business Address 4700 SPRING ST #304 LA MESA CA 91942 619-702-1404
Regen BioPharma Inc (Filer) CIK: 0001589150 (see all company filings)

IRS No.: 455192997 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 333-191725 | Film No.: 162062445
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences